HFS
AMPH icon

Hughes Financial Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Hughes Financial Services’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20 Buy
+1
New +$20 ﹤0.01% 1755
2026
Q1 		– Sell
-24
Closed -$643 – 1722
2025
Q4 		$643 Hold
24
– – ﹤0.01% 866
2025
Q3 		$627 Buy
+24
New +$620 ﹤0.01% 854

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Hughes Financial Services's AMPH Position: Q2 2026 in Review

Hughes Financial Services opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 1 share worth $20. The stake represents ﹤0.01% of the portfolio and ranks #1755 among its holdings. This is a return to the name: Hughes Financial Services previously reported a position in AMPH as recently as Q4 2025.

Hughes Financial Services first reported a position in AMPH in Q3 2025 and has held it in 3 quarters since. The position peaked at $643 in Q4 2025. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Hughes Financial Services held 1 share of Amphastar Pharmaceuticals worth $20 as of Q2 2026.
  • Amphastar Pharmaceuticals was a new Hughes Financial Services position in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1755 holding.
  • Hughes Financial Services first reported a position in Amphastar Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Hughes Financial Services's Amphastar Pharmaceuticals position peaked at $643 in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.